Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective.
Hospital de Clínicas de Porto Alegre, Divisão de Farmácia Clínica, Porto Alegre, RS, Brazil. Electronic address: lucasokumura@yahoo.com.br.
Lucas Miyake
LM
Okumura
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000378:metabolism; D000935:Antifungal Agents / Q000493:pharmacokinetics*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics*; D006660:Histoplasmosis / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D017964:Itraconazole / Q000493:pharmacokinetics*; D019438:Ritonavir / Q000493:pharmacokinetics*
D000935:Antifungal Agents; D017320:HIV Protease Inhibitors; D017964:Itraconazole; D019438:Ritonavir